Does the occurrence of certain rare cancers indicate an inherited cancer susceptibility?

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Familial Cancer

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1023/A:1023265919884PMID 14574163
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Seven New Mutations in hMSH2, an HNPCC Gene, Identified by Denaturing Gradient-Gel Electrophoresis

  2007cited by this paper
• Hereditary Nonpolyposis Colorectal Cancer ( HNPCC )

  2006cited by this paper
• High frequency of microsatellite instability and loss of mismatch‐repair protein expression in patients with double primary tumors of the endometrium and colorectum

  2002cited by this paper
• Leigh disease associated with a novel mitochondrial DNA ND5 mutation

  2002cited by this paper
• Cancer Incidence in BRCA1 mutation carriers.

  2002cited by this paper
• The risk of subsequent primary cancers after colorectal cancer in southeast England

  2002cited by this paper
• Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis.

  2001cited by this paper
• Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer.

  2001cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland)

  2001influential reference
• Small intestinal neoplasms.

  2001cited by this paper
• Bethesda Guidelines: Relation to Microsatellite Instability and MLH1 Promoter Methylation in Patients with Colorectal Cancer

  2001cited by this paper
• Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.

  2001cited by this paper
• Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England

  2001cited by this paper
• The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer.

  2001cited by this paper
• A genetic epidemiological study of carcinoma of the fallopian tube.

  2001cited by this paper
• Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations.

  2000cited by this paper
• A comparison of fluorescent SSCP and denaturing HPLC for high throughput mutation scanning

  2000cited by this paper
• BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers.

  2000cited by this paper
• Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.

  2000cited by this paper
• The Interaction of the Human MutL Homologues in Hereditary Nonpolyposis Colon Cancer*

  1999cited by this paper
• Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing.

  1999cited by this paper
• Identifying and screening patients at high risk of colorectal cancer in general practice

  1999cited by this paper
• Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations.

  1999cited by this paper
• Cancer risks in BRCA2 mutation carriers.

  1999cited by this paper
• The protein truncation test: A review.

  1999influential reference
• New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

  1999cited by this paper
• Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers.

  1999cited by this paper
• The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes.

  1999cited by this paper
• Missense mutations in hMLH1 associated with colorectal cancer

  1999cited by this paper
• Cancer risk in mutation carriers of DNA‐mismatch‐repair genes

  1999cited by this paper
• Validation and simplification of Bethesda guidelines for identifying apparently sporadic forms of colorectal carcinoma with microsatellite instability

  1999cited by this paper
• Hereditary nonpolyposis colorectal cancer (HNPCC)

  1999cited by this paper
• The protein truncation test: A review

  1999cited by this paper
• Genetic implications of double primary cancers of the colorectum and endometrium.

  1998cited by this paper
• Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls.

  1998cited by this paper
• Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.

  1998cited by this paper
• A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines.

  1997cited by this paper
• Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred.

  1997cited by this paper
• Use of SSCP analysis to identify germline mutations in HNPCC families fulfilling the Amsterdam criteria

  1997cited by this paper
• Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families

  1996cited by this paper
• Identification of novel germline hMLH1 mutations including a 22 kb Alu-mediated deletion in patients with familial colorectal cancer.

  1996cited by this paper
• Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.

  1996cited by this paper
• Recent advances in understanding of genetic susceptibility to breast cancer.

  1996cited by this paper
• Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites.

  1996cited by this paper
• Mutations of the BRCA2 gene in ovarian carcinomas.

  1996cited by this paper
• BRCA2 mutations in primary breast and ovarian cancers

  1996cited by this paper
• Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.

  1996cited by this paper
• Mutation screening in the hMLH1 gene in Swedish hereditary nonpolyposis colon cancer families.

  1995cited by this paper
• Pancreas cancer as a second primary malignancy. A population‐based study

  1995cited by this paper
• Detection of new mutations in six out of 10 Swiss HNPCC families by genomic sequencing of the hMSH2 and hMLH1 genes.

  1995cited by this paper
• Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1995cited by this paper
• Unusual case of Smith-Lemli-Opitz syndrome "type II".

  1995cited by this paper
• Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis.

  1995cited by this paper
• Family history of colorectal tumours and implications for the adenoma-carcinoma sequence: a case control study.

  1995cited by this paper
• Rapid detection of BRCA1 mutations by the protein truncation test

  1995cited by this paper
• Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families

  1994cited by this paper
• Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations.

  1994cited by this paper
• A population based study

  1993cited by this paper
• Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome.

  1993cited by this paper
• Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis.

  1993cited by this paper
• What is the true incidence of primary fallopian tube carcinoma?

  1993cited by this paper
• Extracolonic cancer in hereditary nonpolyposis colorectal cancer

  1993cited by this paper
• Adenocarcinoma of the proximal small intestine. A marker for familial and multicentric cancer?

  1992cited by this paper
• The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)

  1991cited by this paper
• Breast cancer as a risk factor for other primary malignant diseases. A nationwide cohort study.

  1984cited by this paper
• Multiple primary cancer. Thirty patients with three or more primary cancers.

  1975cited by this paper
• [Multiple primary cancer].

  1956cited by this paper

• Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature Review

  2017cites this paper
• Analyse von im Lynch-Syndrom identifiziertenMLH1-Keimbahnmutationenauf molekulare und zelluläre Aspekteder DNA Mismatch-Reparatur

  2012cites this paper
• Supplementary Tables

  2010cites this paper
• Uncertain pathogenicity of MSH2 variants N127S and G322D challenges their classification

  2008cites this paper
• Genetics and Molecular Biology of Pancreatic and Biliary Cancers

  2007cites this paper
• The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer.

  2006cites this paper
• Cancer characteristics in Swedish families fulfilling criteria for hereditary nonpolyposis colorectal cancer.

  2005cites this paper
• Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study

  2004cites this paper